Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Telomeres and telomerase linked to cancer, age-related changes

March 15, 1999

Sangamo enters agreement with Japan Tobacco for validation of novel gene targets

March 12, 1999

Genelabs presents gene switch application

March 10, 1999

Novel AD and metabolic syndrome targets as focus of Exelixis and P&U collaboration

March 8, 1999

KV Pharmaceutical and Pfizer sign licensing agreement for oral delivery system

March 4, 1999

Positive efficacy and safety results support clinical testing of ViaStem

March 4, 1999

HMN-1108: new small-molecule compound specific for nNOS

March 2, 1999

LeukoSite and Medarex expand HuMab-Mouse licensing agreement

March 2, 1999

Atrix expands drug delivery patent portfolio

March 1, 1999

Palatin awarded 4th and 5th SBIR grants for MIDAS technology

March 1, 1999

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...